Načítá se...
Population pharmacokinetic analysis of tacrolimus in Chinese myasthenia gravis patients
The importance of tacrolimus in the treatment of myasthenia gravis (MG) as a substitute for corticosteroid-dependent immunosuppressive therapy is increasing. Thus far, however, no population pharmacokinetic (PopPK) analysis of tacrolimus in treating MG patients has been published. This article aimed...
Uloženo v:
| Vydáno v: | Acta Pharmacol Sin |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5547552/ https://ncbi.nlm.nih.gov/pubmed/28552913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/aps.2016.174 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|